EUVIMEDEUVIMED entdecken
Open Access

Clinical Outcomes and Toxicity of CT-guided High Dose-rate Brachytherapy in Women With Locally-advanced Cervical Cancer

Vitaliana DE Sanctis, Giuseppe Facondo, Gianluca Vullo, Dimitri Anzellini, Giuseppe Sanguineti, Alessia Nardangeli, Luca Marmiroli, Francesca Tortoreto, Piercarlo Gentile, Ivan Annessi, Vittorio Donato, Cinzia Chiostrini und 4 weitere

Cancer Diagnosis & Prognosis · 03.03.2023 · 3 (2) · 194-200

DOI: 10.21873/cdp.10201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Diagnosis & Prognosis, online erschienen am 03.03.2023. Verfasst von Vitaliana DE Sanctis und 15 weiteren Autor:innen. Beteiligte Einrichtung: Radiotherapy Oncology, Department of Medicine and Surgery and Translational Medicine, Sapienza University of Rome, S. Andrea Hospital, Rome, Italy. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aim: To evaluate the outcome and toxicities in patients with locally advanced cervical cancer (LACC) treated with radiochemotherapy and intracavitary brachytherapy. Patients and Methods: This study included 67 patients with LACC treated between 2010 and 2018. The most represented stage was FIGO IIB. The patients were treated with external beam radiotherapy (EBRT) to the pelvis and boost to the cervix and parametrials. Concomitant chemotherapy (CHT) with cisplatin (CDDP) 40 mg/mq was planned. Subsequently, the patients underwent CT-based endouterine brachytherapy (BT). The response was evaluated at 3 months with PET-CT and/or pelvic magnetic resonance imaging (MRI). Since then, the patients have been followed with clinical instrumental controls every 4 months for the first 2 years and every 6 months for the following 3 years. Local response was assessed with pelvic MRI and/or PET-CT scan at the end of intracavitary BT) according to RECIST 1.1 criteria.

Results

The median duration of treatment was 55 days (range=40-73 days). The prescription dose to the planning target volume (PTV) was delivered in 25 to 30 (median 28) daily fractions. The EBRT median dose to the pelvis and gross tumor volume were 50.4 Gy (range=45-56.25) and 61.6 Gy (range=45-70.4), respectively. The 1-year, 2-year, 3-year, and 5-year overall survival rates were 92.44%, 80.81%, 78.84%, and 76.45% respectively. The actuarial 1-year, 2-year, 3-year, and 5-year disease-free survival rates were 89.5%, 83.6%, 81%, and 78.2% respectively.

Conclusion

This study analyzed acute and chronic toxicity, survival, and local control in cervical cancer patients treated with IMRT followed by CT-planned high dose rate-brachytherapy. Patients demonstrated satisfactory outcomes and incidence of acute and late toxicities.

Schlagwörter

Stichwörter der Autor:innen

CervixHDR-BTLACCbrachytherapyradiotherapy

Autor:innen und Institutionen

  • Radiotherapy Oncology, Department of Medicine and Surgery and Translational Medicine, Sapienza University of Rome, S. Andrea Hospital, Rome, Italy.
  • Department of Radiotherapy, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • U.O.C. Radiotherapy, S. Giovanni Calibita Fatebenefratelli Hospital - Amethyst Radioterapia Italia, Rome, Italy.
  • Department of Radiation Oncology, San Pietro Fatebenefratelli (FBF), Rome, Italy.
  • Radiation Oncology Department, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy.
  • Department of Radiotherapy, "Sapienza" University of Rome, Policlinico Umberto I, Rome, Italy.

Zitieren

APA

DE Sanctis, V., Facondo, G., Vullo, G., Anzellini, D., Sanguineti, G., Nardangeli, A., Marmiroli, L., Tortoreto, F., Gentile, P., Annessi, I., Donato, V., Chiostrini, C., Tombolini, V., DE Felice, F., Valeriani, M., & Osti, M. F. (2023). Clinical Outcomes and Toxicity of CT-guided High Dose-rate Brachytherapy in Women With Locally-advanced Cervical Cancer. Cancer Diagnosis & Prognosis, 3(2), 194-200. https://doi.org/10.21873/cdp.10201

Vancouver

DE Sanctis V, Facondo G, Vullo G, Anzellini D, Sanguineti G, Nardangeli A, et al. Clinical Outcomes and Toxicity of CT-guided High Dose-rate Brachytherapy in Women With Locally-advanced Cervical Cancer. Cancer Diagnosis & Prognosis. 2023;3(2):194-200. doi:10.21873/cdp.10201

BibTeX
@article{DESanctis2023,
  author = {DE Sanctis, Vitaliana and Facondo, Giuseppe and Vullo, Gianluca and Anzellini, Dimitri and Sanguineti, Giuseppe and Nardangeli, Alessia and Marmiroli, Luca and Tortoreto, Francesca and Gentile, Piercarlo and Annessi, Ivan and Donato, Vittorio and Chiostrini, Cinzia and Tombolini, Vincenzo and DE Felice, Francesca and Valeriani, Maurizio and Osti, Mattia Falchetto},
  title = {Clinical Outcomes and Toxicity of CT-guided High Dose-rate Brachytherapy in Women With Locally-advanced Cervical Cancer},
  journal = {Cancer Diagnosis & Prognosis},
  year = {2023},
  volume = {3},
  number = {2},
  pages = {194--200},
  doi = {10.21873/cdp.10201}
}
Kostenlos starten →